OTC Artificial Tears Market Analysis
The global over-the-counter (OTC) artificial tears market is expected to grow significantly, reaching US$ 6.25 billion by 2030, according to Renub Research. This surge in market growth can be attributed to a growing awareness of eye health, particularly the increasing prevalence of dry eye syndrome, which has led to heightened demand for OTC artificial tears. Consumers are turning to these products for quick relief from symptoms like dryness, irritation, and inflammation, appreciating the convenience and accessibility of solutions that do not require a prescription. This trend represents a shift toward proactive eye care, with many people seeking accessible and effective remedies for maintaining eye health on-the-go.
Request a free sample copy of the report: https://www.renub.com/otc-artificial-tears-market-p.php
Rising Demand Driven by Dry Eye Syndrome and Changing Lifestyles
One of the primary drivers of the global OTC artificial tears market is the growing prevalence of dry eye syndrome. Estimates of its occurrence vary widely, with reports suggesting it affects anywhere from 9.5% to 90% of the global population, depending on the region and the study. Dry eye syndrome, while not life-threatening, can significantly impact the quality of life, causing discomfort, pain, and even vision problems if left untreated. As a result, many individuals are seeking OTC artificial tears for immediate relief from these symptoms.
Beyond the increasing awareness of dry eye syndrome, several lifestyle factors are fueling demand for artificial tears. The rise of digital screen use—especially among younger generations—has contributed to a surge in eye strain and discomfort, further exacerbating dry eye conditions. According to data from the CDC, children aged 8-18 spend an average of 7.5 hours daily on screens, with a substantial portion of this time dedicated to television and smartphones. This prolonged screen exposure leads to reduced blinking and increased evaporation of tear film, aggravating dry eye symptoms. Additionally, the growing geriatric population and an uptick in eye surgeries are also contributing to the rising demand for OTC artificial tears, especially for post-operative care.
Global Market Growth: Projected CAGR of 4.87% from 2024 to 2030
The OTC artificial tears market is projected to expand at a CAGR of 4.87% from 2024 to 2030. Key factors driving this growth include:
- Increased Prevalence of Dry Eye Syndrome: The number of individuals suffering from dry eye syndrome is rising globally, especially among older populations, further boosting the demand for artificial tears.
- Technological Advancements: The continuous development of preservative-free, highly effective eye drops and innovative delivery systems is enhancing the appeal of OTC artificial tears. Companies are launching new products that cater to specific needs, such as longer-lasting moisture or blue light protection.
- Changing Lifestyles: Modern habits, such as prolonged screen time and environmental stressors like air pollution and dry climates, are increasing the incidence of dry eyes, prompting consumers to seek easy-to-use, on-the-go solutions like OTC artificial tears.
Key Market Segments: Solutions Lead the Way
The global OTC artificial tears market is categorized into different product types, including solutions, ointment, emulsions, gels, sprays, and suspensions. Among these, solutions are the most widely used and dominant product type. The popularity of solutions can be attributed to their ease of use, quick relief, and versatility. These liquid drops can be easily applied, providing fast and effective relief for eye dryness and irritation. They are especially popular among individuals with sensitive eyes or those who wear contact lenses, as the liquid form is gentle and easy to use. As a result, solutions maintain a leading position in the market, accounting for a large share of the overall market growth.
Dry Eye Syndrome: The Leading Application for OTC Artificial Tears
By application, dry eye syndrome is the most significant driver of growth in the OTC artificial tears market. With the increasing awareness of this condition and a growing focus on its diagnosis, the demand for OTC artificial tears is expected to rise substantially. Contributing factors include:
- Aging Population: As people age, they are more likely to experience dry eye symptoms due to reduced tear production and changes in tear composition. This demographic shift is driving a rise in demand for artificial tears.
- Prolonged Screen Time: As mentioned earlier, the widespread use of digital devices has led to computer vision syndrome, which often includes dry eye symptoms like irritation, burning, and itching. This, in turn, is boosting the market for OTC artificial tears.
- Environmental Factors: Air pollution, dust, and harsh weather conditions also contribute to eye dryness, making OTC artificial tears a go-to solution for many people looking for immediate relief.
Distribution Channels: Drugstores and Supermarkets Lead the Charge
The distribution channels for OTC artificial tears include drugstores & supermarkets, online pharmacies, retail pharmacies, and other specialized outlets. Among these, drugstores and supermarkets are likely to remain the dominant distribution channels in the global market. These retail outlets offer a wide variety of OTC artificial tear products, making them easily accessible to a large number of consumers. The convenience of purchasing products from well-known, trusted locations also makes these stores the preferred choice for many people seeking quick solutions for their eye care needs.
With the increasing number of individuals seeking OTC remedies for eye discomfort, drugstores and supermarkets are well-positioned to meet this demand by offering a broad range of options in easily accessible formats. Online pharmacies are also emerging as a significant channel, especially with the rise of e-commerce, making it easier for consumers to order their preferred products from home.
United States: A Key Market for OTC Artificial Tears
The United States is one of the largest and fastest-growing markets for OTC artificial tears. The growing prevalence of dry eye disease in the U.S. is a major factor driving this expansion. It is estimated that between 16 million and 49 million Americans suffer from dry eye disease, with a higher prevalence among women. The rise in screen time, coupled with environmental factors like air pollution and dry climates, has intensified the need for eye care products such as artificial tears.
Additionally, the U.S. market benefits from high disposable incomes, advanced healthcare infrastructure, and regulatory approvals for various innovative artificial tear products. As more people become aware of the symptoms and treatment options for dry eye syndrome, the demand for OTC artificial tears is expected to continue growing in the coming years.
Key Players in the Global OTC Artificial Tears Market
The global OTC artificial tears market is competitive, with several prominent players driving innovation and market expansion. Key companies in the market include:
- AbbVie Inc.
- Akorn Inc.
- Alcon
- Bausch Health Companies Inc.
- Johnson & Johnson
- Nicox S.A.
- Novartis AG
- Santen Pharmaceutical Co. Ltd.
- Sun Pharmaceutical Industries Ltd.
These companies are actively involved in the development and launch of new products to address a variety of eye care needs, from basic dryness relief to specialized formulations for people with specific eye conditions.
Recent Developments:
- Johnson & Johnson Vision Care launched a phase II clinical trial in December 2023 to assess multi-dose preservative-free lubricating eye drops, packaged in Novelia® Eye Dropper for non-contact lens users.
Related Report :
Global Self-Monitoring Blood Glucose Device Market
Saudi Arabia Contact Lenses Market
About the Company:
Renub Research is a Market Research and Consulting Company. We have more than 15 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food Beverages, Power Energy, Information Technology, Telecom Internet, Chemical, Logistics Automotive, Consumer Goods Retail, Building, and Construction, Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.
Media Contact:
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +91-120-421-9822 (IND) | +1-478-202-3244 (USA)
Email: rajat@renub.com